REVELATION BIOSCIENCES
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place.
REVELATION BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2020-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.revbiosciences.com
Total Employee:
11+
Status:
Closed
Contact:
1-650-800-3717
Total Funding:
27.26 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Board_member
2021-01-01
Current Employees Featured
Chester S. Zygmont, III Co-Founder, CFO and Director @ Revelation Biosciences
Co-Founder, CFO and Director
James M. Rolke CEO @ Revelation Biosciences
CEO
2020-06-01
Founder
Stock Details
Investors List
National Securities Corporation
National Securities Corporation investment in Post-IPO Equity - Revelation Biosciences
Global Health Funds
Global Health Funds investment in Post-IPO Equity - Revelation Biosciences
Official Site Inspections
http://www.revbiosciences.com Semrush global rank: 2.62 M Semrush visits lastest month: 6.62 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Revelation Biosciences"
Revelation BioSciences
Latest News: November 12, 2024 - Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply. November 8, 2024 - Revelation Biosciences, Inc. Announces …See details»
About Us - Revelation BioSciences
Revelation Biosciences, Inc. is a clinical stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity.See details»
Revelation BioSciences - Overview, News & Similar companies
May 10, 2024 · Revelation BioSciences contact info: Phone number: (650) 800-3717 Website: www.revbiosciences.com What does Revelation BioSciences do? Founded in 2020, …See details»
Revelation Biosciences - Crunchbase Company Profile & Funding
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a healthier place. Revelation Biosciences announced financial results for the three …See details»
Revelation Biosciences Inc. Announces Commencement of First in …
Mar 4, 2024 · Revelation Biosciences, Inc. is a life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary …See details»
Revelation Biosciences, Inc. Completes the GMP Manufacture of …
Nov 12, 2024 · GMP compliant manufacturing of Gemini is a pivotal requirement for an Investigation New Drug (IND) application with FDA. The Company intends to utilize the current …See details»
Revelation Biosciences Inc. and Vanderbilt University …
Oct 6, 2022 · SAN DIEGO-- ( BUSINESS WIRE )--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on the development of immunologic based therapies...See details»
Revelation Biosciences Inc. Announces Future Clinical …
Nov 18, 2022 · Revelation Biosciences, Inc. is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease.See details»
Revelation Biosciences - VentureRadar
Website: https://www.revbiosciences.com/ Develops innate immune system therapeutics and diagnostics for disease prevention and treatment, including a broad anti-viral nasal drop …See details»
Revelation Biosciences Inc. Announces Positive Results in …
Oct 25, 2022 · Revelation Biosciences, Inc. is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease.See details»
Revelation Biosciences, Inc. (REVB) - Stock Analysis
6 days ago · Get a real-time Revelation Biosciences, Inc. (REVB) stock price quote with breaking news, financials, statistics, charts and more.See details»
Revelation Biosciences Announces Phase 1 Clinical Study of …
SAN DIEGO, June 24, 2024 -- (BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused …See details»
News — Revelation BioSciences
November 12, 2024. Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply . November 8, 2024. Revelation Biosciences, Inc. Announces Financial …See details»
Revelation Biosciences Raises $7.76 Million in Equity
Jan 24, 2022 · Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. …See details»
Revelation Biosciences Inc. Announces First Group of
Jan 20, 2022 · Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. …See details»
Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split ...
SAN DIEGO, January 23, 2024--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), announced today that, on January 25, 2024, the Company will implement a 1 …See details»
Revelation Biosciences Inc. Announces Closing of $15.6 Million …
Feb 13, 2023 · SAN DIEGO-- ( BUSINESS WIRE )--Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused …See details»
Revelation Biosciences Inc. Announces Topline Data for
SAN DIEGO, July 22, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused …See details»
Revelation Biosciences Inc. Announces Pricing of $6.2 Million
Feb 1, 2024 · Revelation Biosciences Inc., a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today announced …See details»
Revelation Biosciences Inc (REVB) Stock Price & News - Google
Get the latest Revelation Biosciences Inc (REVB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»